White House says Trump's deals with pharmaceutical companies offer billions in savings
Summary
The White House says that President Donald Trump’s deals with drug companies to lower U.S. prescription drug prices to levels seen in other wealthy countries could save $529 billion over 10 years. These savings include $64.3 billion for government health programs like Medicaid, but some lawmakers question the accuracy and transparency of these claims.Key Facts
- President Trump made deals with 17 major drug companies to reduce U.S. prescription drug prices.
- White House economists estimate these deals could save $529 billion over the next 10 years.
- Federal and state government programs like Medicaid could save about $64.3 billion from these deals.
- Details of the agreements have not been fully shared because of sensitive market information.
- Some Democrats have asked for public disclosure of the deals to verify the savings.
- Americans spent $467 billion on prescription drugs in 2024, making these savings significant.
- Experts say not all savings may reach patients, as many already get discounts through insurance.
- The Congressional Budget Office estimated similar plans could cut drug prices by over 5%, but savings may decrease over time as companies react.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.